Clinical Trial Update: IASO-782 in Autoimmune Hematological Diseases [Phase 1]

View source ↗

Summary

Phase 1 clinical trial update for IASO-782 in autoimmune hematological diseases, including immune thrombocytopenia and autoimmune hemolytic anemia. The study is…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Autoimmune Hemolytic Anemia
• Immune Thrombocytopenia

Drugs mentioned

• IASO-782

Snippet

Sponsor: Shanghai IASO Biotechnology Co., Ltd | Conditions: Autoimmune Thrombocytopenia, Warm Autoimmune Haemolytic Anaemia | Phase 1 | Status: NOT_YET_RECRUITING